Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Preparing for a memory clinic visit starts weeks before your appointment. The key is arriving with organized documentation, a family member who knows the patient well, and realistic expectations about what the clinic will do. Memory clinics rely heavily on accurate information from both the patient and a knowledgeable informant—research from UCSF, Mass General, and Northwestern shows that a patient’s own account is often incomplete, which is why clinics specifically ask for a family member to attend and bring detailed medical records. A memory clinic visit differs from a routine doctor’s appointment.
Clinicians spend time on detailed cognitive screening, review medication lists for drugs that can impair thinking, and reconstruct the timeline of how thinking and memory have changed. Studies show that families who arrive prepared—with medications in original bottles, prior brain imaging films, and a completed pre-visit questionnaire—move through the appointment more efficiently and receive more accurate diagnoses. The experience is typically structured, sometimes formal, and can feel lengthy. The patient undergoes testing while family members provide collateral history. Understanding what to expect and how to prepare removes uncertainty and helps families participate actively in the diagnostic process.
Related guide: Cognitive Tests for Dementia — our comprehensive resource on this topic.
Table of Contents
- What Documentation Should Families Bring to a Memory Clinic?
- What Cognitive Tests Will the Patient Undergo?
- How Should Families Prepare the Medical History?
- What Is the Family Member’s Role During the Visit?
- What Treatments and Follow-Up Should Families Expect After the Visit?
- Laboratory and Imaging Tests at a Memory Clinic
- Common Questions Families Ask Before and After the Appointment
What Documentation Should Families Bring to a Memory Clinic?
clinics have a standard list of items they ask families to bring, and these requests reflect what clinicians actually need to make an accurate diagnosis. Bring every medication in its original container—this includes prescription drugs, over-the-counter medicines, vitamins, and supplements. Clinics specifically request original bottles rather than a typed list because dosages need to be verified and because several drug classes can impair cognition and mimic dementia symptoms: benzodiazepines and other sleep aids, codeine-containing pain relievers, and anticholinergic medications such as some antidepressants and bladder medications. Also bring prior brain imaging and the actual films or images, not just a mention that scans were done. If the patient has had an MRI, CT, PET, or SPECT scan at any time, clinics want to review those images alongside the written reports.
Bring old medical records and results of any previous cognitive testing. Many clinics mail a pre-visit questionnaire packet in advance; complete this and bring it with you. Plan to arrive 10–20 minutes early to finish additional paperwork. Some families find it helpful to bring a pen, paper, and two copies of any worksheets so the family member and patient can reference them together during the appointment. A practical limitation: some clinics require the patient to attend with a close family member or reliable informant who knows the patient’s baseline functioning and recent changes, and will not proceed with a meaningful evaluation without one. Confirm this requirement when booking, because scheduling a visit with only the patient—without a knowledgeable family member present—may result in postponement or a less complete assessment.
What Cognitive Tests Will the Patient Undergo?
Memory clinics use brief standardized cognitive screening tests that take 3 to 15 minutes. The most common are the Montreal Cognitive Assessment (MoCA), the Mini-Mental State Examination (MMSE), the Mini-Cog, and the Clock Drawing Test (CDT). Families should understand what these tests measure so they can track the patient’s performance over time and recognize improvement or decline. The MoCA assesses executive function, memory, attention, language, visuospatial skills (clock and cube drawing), abstraction, and orientation. It takes 10 to 15 minutes and has approximately 90% sensitivity for detecting dementia and 87% specificity, making it particularly strong for identifying *early* cognitive impairment and mild cognitive impairment—cases that the MMSE may miss. The MMSE measures orientation, attention, recall, language, and ability to follow commands in about 7 to 8 minutes, with a 30-point scale; a score of 24 or below raises concern.
The MMSE has high specificity (92.3%) but is *less sensitive* for detecting early or mild impairment, meaning a normal MMSE does not rule out early dementia. The Mini-Cog is faster—about 3 minutes—and combines a 3-word delayed recall task with clock drawing. A score below 3 suggests dementia; a score below 4 captures more cases at the cost of false positives. The Clock Drawing Test, often embedded within other screens, checks visuospatial skills and executive function and serves as a quick surrogate screen. An important warning: all of these are *screening* tools, not diagnostic instruments. They must be combined with a thorough history, a physical and neurological examination, blood tests, and imaging to reach a diagnosis. Education level, language background, and depression can all confound these scores, which is why a clinician interprets them in context.
How Should Families Prepare the Medical History?
The timeline of cognitive and behavioral change is often the single most valuable information a family can provide. Prepare to describe when memory loss or thinking problems were first noticed, how quickly changes developed, and whether symptoms are progressing. Clinics also need to know about vascular risk factors—hypertension, diabetes, high cholesterol—because these increase the risk of vascular dementia and cognitive decline from small strokes. Describe any prior neurological events: previous stroke, Parkinson’s disease, head trauma or traumatic brain injury, or seizures.
Mental health history matters: depression and anxiety can both cause and worsen cognitive symptoms, and sleep disorders—insomnia, sleep apnea—can mimic or accelerate dementia. Family history of dementia is important to document, particularly if *young-onset dementia* (before age 65) appears in first-degree relatives, because this pattern can signal a rare inherited genetic form such as familial Alzheimer’s disease or frontotemporal dementia, which may warrant genetic counseling. Clinics also run standard laboratory tests: thyroid function (thyroid disease can cause cognitive decline) and vitamin B12 levels (B12 deficiency causes reversible cognitive impairment). Knowing this in advance helps families understand why these tests are ordered. A practical limitation: family history can carry genetic implications, and while it is important to document, avoid overinterpreting a single affected relative, because most dementia is *not* simply inherited—clinicians weigh the age of onset and the number of affected relatives before suspecting a genetic form.
What Is the Family Member’s Role During the Visit?
The family member who attends is functioning as an *informant* and *advocate*, not a passive observer. Clinicians rely on this person to fill gaps in the patient’s self-report—this is especially important because patients with cognitive impairment often do not recognize or report changes in their own functioning (a phenomenon called anosognosia). Come with specific examples of functional decline: missed bills, repeated questions, getting lost in familiar places, forgetting recent conversations, or changes in judgment or personality. These examples are more clinically useful than a general statement like “his memory is bad.” Take notes during the appointment and bring written questions.
Common topics families ask about include the specific diagnosis and how it was reached, appropriate treatments (medications and non-drug strategies), whether the patient qualifies for clinical trials, lifestyle changes that may slow progression, the expected course of illness and how to recognize when more intensive support is needed, caregiver support programs (respite care, support groups, caregiver education), and mental-health and coping resources for both patient and caregiver. Some clinicians will ask to speak with the patient and informant separately so each can speak candidly. This is normal practice and allows the clinician to assess the patient’s self-awareness and to hear the caregiver’s perspective without the patient present. A research finding worth noting: studies show that patients and caregivers often *disagree* on the patient’s functioning and quality of life after a diagnostic visit, reminding us that the caregiver’s perspective and the patient’s own experience can legitimately differ—and both matter in planning care.
What Treatments and Follow-Up Should Families Expect After the Visit?
The memory clinic typically provides a diagnosis and staging assessment, integrating the screening results, physical exam, laboratory tests, and imaging findings. Depending on the diagnosis, families should expect discussion of treatment options. For mild-to-moderate Alzheimer’s disease, clinicians may recommend cholinesterase inhibitors—donepezil, rivastigmine, or galantamine—which support memory and thinking by slowing the breakdown of acetylcholine. For moderate-to-severe Alzheimer’s, memantine (an NMDA receptor antagonist) is used. These are currently the only licensed symptomatic treatments. More recently, anti-amyloid monoclonal antibodies—lecanemab (Leqembi) and donanemab (Kisunla)—have been approved for *early* Alzheimer’s disease and mild cognitive impairment due to Alzheimer’s pathology. These are given as intravenous infusions (lecanemab every two weeks).
They target amyloid plaques in the brain and require careful patient selection and monitoring for amyloid-related imaging abnormalities. Families should understand that these drugs apply only to very early disease stages and require regular MRI monitoring. Non-pharmacological strategies—cognitive training, physical activity, cognitive stimulation, and social engagement—are recommended for all stages. The clinic may also refer the patient to clinical trials, particularly if standard treatments are not suitable or the family is interested in experimental approaches. An important warning: research documents a significant *communication gap between memory clinics and primary care*, leaving families feeling “abandoned” after the initial evaluation. Ongoing prescribing and monitoring of medications often transition back to the patient’s primary-care provider, and coordination between the clinic and primary care is not always seamless. A single coordinated point of contact and a primary-care provider with dementia expertise help bridge this gap.
Laboratory and Imaging Tests at a Memory Clinic
Standard laboratory tests ordered during a memory clinic evaluation include blood work to check thyroid function and vitamin B12 levels, because thyroid disease and B12 deficiency are reversible causes of cognitive impairment that can mimic dementia. Brain imaging—MRI is most common, sometimes CT or PET depending on the clinic’s resources—helps exclude stroke, tumor, or other structural causes and may show patterns typical of Alzheimer’s disease (atrophy in specific brain regions) or vascular dementia (evidence of prior small strokes).
Families should ask whether imaging results will be shared in writing and whether they will receive a copy of imaging films for their own records or to bring to future appointments with other specialists. The combination of cognitive screening, history, lab work, and imaging is what allows clinicians to move from “the patient has cognitive impairment” to a specific diagnosis—Alzheimer’s disease, vascular dementia, dementia with Lewy bodies, frontotemporal dementia, or mild cognitive impairment of uncertain etiology. A single test never determines the diagnosis alone.
Common Questions Families Ask Before and After the Appointment
Families often wonder whether the memory clinic visit will result in a definitive diagnosis on the same day. The answer is usually no: clinicians need time to integrate test results, review imaging, and sometimes repeat cognitive testing, and a preliminary diagnosis may be communicated at the appointment with a follow-up letter detailing final conclusions.
Families also frequently ask whether the patient’s primary-care doctor should attend the memory clinic visit; in most cases, the answer is no, but the clinic will communicate findings to the primary-care provider in writing. Another common concern is cost and insurance coverage; clinics typically verify insurance eligibility in advance, though families should confirm whether there are out-of-pocket costs for testing or follow-up imaging. Some families ask whether they should tell the patient about the clinic visit beforehand or keep it a surprise; clinicians recommend transparency and preparing the patient with honest, straightforward language suited to their level of understanding—”We’re going to see a doctor who specializes in memory to figure out what’s causing the problems you’ve been having.”.
- —
